IMB Dx is a precision oncology company focused on developing solutions for safe & accurate cancer diagnosis & monitoring. We created AlphaLiquid®, a minimally-invasive liquid biopsy method which requires only a single blood draw to detect cancer and monitor its progress. With AlphaLiquid®, we offer a comprehensive genomic profile of the tumor and matching therapies as well as clinical trial information. Since we began our research in 2014, our goal has remained the same: to make cancer diagnosis accessible and affordable to as many cancer patients as possible. For more information, please visit us at www.imbdx.com/eng/ or contact us at [email protected].
We're tracking IMBdx's market expansion
How IMBdx's international expansion compares to its competitors
IMBdxYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 IMBdxYou | 0 | 0 | — | 0 | 0 |
IMBdx 첨단바이오 융합인재(AI전문가) 모집
View postingSeoul, South Korea · 3w ago
Global BD Manager
View postingSeoul, South Korea · 8mo ago
Global Business Development Manager
View postingSeoul, South Korea · 8mo ago
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Multiple Korean companies reported Q2 2025 financial results, including Kiwoom Securities, SOOP, GS E&C, and others. Several firms announced investments, contracts, and corporate actions.
IMBdx's IPO was oversubscribed with 10.7 trillion won in subscription deposits, attracting 465,671 subscribers with a competition ratio of 2654.2 to 1.
Teragen Bio selected for PAVE project to develop personalized anticancer vaccines. Collaborating with partners in NeoVax-K Consortium, aiming to improve prediction accuracy to over 90%.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about IMBdx's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
